Artikel ; Online: Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.
Journal of immunotherapy (Hagerstown, Md. : 1997)
2019 Band 42, Heft 8, Seite(n) 309–312
Abstract: Immune checkpoint inhibitors deeply improved the prognosis of metastatic melanoma or other types of cancer, but their related adverse effects (AEs) can be very severe, especially when the neurological system is touched, as in myasthenia gravis (MG). It ... ...
Abstract | Immune checkpoint inhibitors deeply improved the prognosis of metastatic melanoma or other types of cancer, but their related adverse effects (AEs) can be very severe, especially when the neurological system is touched, as in myasthenia gravis (MG). It is a rare immune AE that can be life-threatening and can be revealed by several symptoms. We report a case of our experience and review the current literature of MG exacerbated or occurring during immunotherapy to describe characteristics of this AE, warn the oncologist about this toxicity, and summarize the treatments conducted. Thirty-four cases of MG were reported, mostly with anti-programmed cell death protein 1 checkpoint inhibitor, and with melanoma. Onset was quick after the first or second infusion. Treatment comprised corticosteroids, prostigmine, and more or less plasmapheresis or immunoglobulins. Prognosis is poor, as 13 patients died after MG. MG is a rare immune-related AE that must be rapidly evoked and treated in case of neurological symptoms emerging after immunotherapy. |
---|---|
Mesh-Begriff(e) | Aged ; Antineoplastic Agents, Immunological/adverse effects ; Female ; Humans ; Melanoma/drug therapy ; Myasthenia Gravis/drug therapy ; Myasthenia Gravis/etiology ; Neostigmine/therapeutic use ; Nivolumab/adverse effects ; Programmed Cell Death 1 Receptor/antagonists & inhibitors |
Chemische Substanzen | Antineoplastic Agents, Immunological ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor ; Nivolumab (31YO63LBSN) ; Neostigmine (3982TWQ96G) |
Sprache | Englisch |
Erscheinungsdatum | 2019-06-26 |
Erscheinungsland | United States |
Dokumenttyp | Case Reports ; Journal Article ; Review |
ZDB-ID | 1064067-8 |
ISSN | 1537-4513 ; 1053-8550 ; 1524-9557 |
ISSN (online) | 1537-4513 |
ISSN | 1053-8550 ; 1524-9557 |
DOI | 10.1097/CJI.0000000000000278 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 1778: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.